Sign up to save your podcasts
Or
Share Ep. 126 - Growing Galapagos, Plus Abortion & Biopharma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep. 126 - Growing Galapagos, Plus Abortion & Biopharma
On the latest BioCentury This Week podcast, a pair of deals demonstrates how Galapagos CEO Paul Stoffels is shifting the Belgian biotech’s strategic focus from small molecules toward a diversified portfolio. Plus: why Friday’s Supreme Court decision to overturn Roe v. Wade sets the stage for legal and legislative battles that could have broad implications for biopharma and how a new crop of Indian biotechs are seeking to offer dramatically cheaper CAR T therapies. This week’s podcast is sponsored by the BioCentury-BayHelix East-West Summit 2022.
Reach us by sending a text
View all episodes
By BioCentury
4.8
3232 ratings
On the latest BioCentury This Week podcast, a pair of deals demonstrates how Galapagos CEO Paul Stoffels is shifting the Belgian biotech’s strategic focus from small molecules toward a diversified portfolio. Plus: why Friday’s Supreme Court decision to overturn Roe v. Wade sets the stage for legal and legislative battles that could have broad implications for biopharma and how a new crop of Indian biotechs are seeking to offer dramatically cheaper CAR T therapies. This week’s podcast is sponsored by the BioCentury-BayHelix East-West Summit 2022.
Reach us by sending a text
More shows like BioCentury This Week
View all
Freakonomics Radio
32,096 Listeners
Bloomberg Intelligence
401 Listeners
Odd Lots
1,985 Listeners
Nature Podcast
771 Listeners
The Long Run with Luke Timmerman
125 Listeners
The Readout Loud
340 Listeners
Making Sense
70 Listeners
Thoughts on the Market
1,307 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
84 Listeners
MIT Technology Review Narrated
260 Listeners
Biotech Hangout
21 Listeners
WSJ's Take On the Week
142 Listeners
The Top Line
17 Listeners
The BioCentury Show
13 Listeners